• Twist Bioscience director Melissa A. Starovasnik sold 1,000 shares on April 1, 2026 at $51 per share.
• Starovasnik beneficially owned 25,722 shares following transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-004333), on April 03, 2026, and is solely responsible for the information contained therein.